SYNERGY(SZ:300636) Zheng Quan Ri Bao·2025-10-24 23:10Core Viewpoint - The company, Tonghe Pharmaceutical, emphasizes the accuracy and completeness of its quarterly financial report, ensuring no false records or misleading statements are present [2][3]. Financial Data - The third-quarter financial report has not been audited [8]. - The company does not require retrospective adjustments or restatements of previous accounting data [3]. - There are no non-recurring profit and loss items applicable for the reporting period [3]. Shareholder Information - The company has provided details on the total number of ordinary shareholders and the top ten shareholders' holdings [5]. - There are no changes in the top ten shareholders due to securities lending activities [5]. Other Important Matters - The company has completed part of the expansion project in its second factory area, with equipment installation and debugging in progress [5].